trial

Computer-Aided Learning for Managing Stress

NCTId NCT02531243
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 25 (actual)
Sponsored by Beth Israel Deaconess Medical Center
Primary completion 2018-01-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
25 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2015-09
Primary completion
2018-01-05
Eligibility
ALL · 12 Years · 30 Years

Interventions & indications

Drugs
CALMS

Sponsors

Beth Israel Deaconess Medical CenterLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Boston Children's HospitalCollaborator

Investigators

1
Kristen Woodberry, MSW, Ph.D.Principal Investigator

Sites

1 total
Boston, United States

Facts & assertions

4 sourced
Enrollment
25
Phase
NA
Primary Completion Date
2018-01-05
Status
COMPLETED
relationships
The graph out of here
drug
CALMS
drug
lead_sponsor
Beth Israel Deaconess Medical Center
company
collaborator
National Institute of Mental Health (NIMH)
company
Boston Children's Hospital
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Kristen Woodberry, MSW, Ph.D.
person